Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

BIT225

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
P7 is the only viral channel encoded by the Hepatitis C Virus (HCV) genome. It is a small, highly hydrophobic protein containing… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2016
2016
OBJECTIVES BIT225 (N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide), a novel acyl-guanidine, is a novel antiviral drug… Expand
2016
2016
BackgroundPrevious studies with BIT225 (N-carbamimidoyl-5-(1-methyl-1H-pyrazol-4-yl)-2-naphthamide) have demonstrated a unique… Expand
  • figure 1
  • figure 2
2015
2015
Background The current standard care therapy for hepatitis C virus (HCV) infection consists of two regimes, namely interferon… Expand
  • table 2
  • figure 1
  • figure 2
  • table 3
  • figure 3
2014
2014
Protein p7 of HCV is a 63 amino acid channel forming membrane protein essential for the progression of viral infection. With this… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
2013
2013
Hepatitis C virus p7 protein is a 63 amino acid polytopic protein with two transmembrane domains (TMDs) and one of the prime… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Review
2012
Review
2012
Acylguanidines are a new class of antiviral compounds with the unique ability to target both RNA polymerase and transmembrane… Expand
  • figure 1
2011
2011
Among its many roles, the HIV-1 accessory protein Vpu performs a viroporin function and also antagonizes the host cell… Expand
Highly Cited
2010
Highly Cited
2010
The novel small molecule, BIT225 (N-[5-(1-methyl-1H-pyrazol-4-yl)-napthalene-2-carbonyl]-guanidine: CAS No. 917909-71-8), was… Expand
Highly Cited
2009
Highly Cited
2009
ABSTRACT Building on previous findings that amiloride analogues inhibit HIV-1 replication in monocyte-derived macrophages (MDM… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4